Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Chronic myeloid leukemia with p190 BCR-ABL : prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis

Animesh Pardanani, Ayalew Tefferi, Mark R. Litzow, Clive Zent, William J. Hogan, Rebecca F. McClure, David Viswanatha

Blood (2009) 114 (16): 3502–3503.

https://doi.org/10.1182/blood-2009-07-234666

Published: 2009

Journal Articles

Combination Chemoimmunotherapy with Pentostatin, Cyclophosphamide and Rituximab Shows Significant Clinical Activity with Low Accompanying Toxicity in Previously Untreated B-Chronic Lymphocytic Leukemia.

Neil Kay, MD, Susan Geyer, PhD, Timothy Call, MD, Tait Shanafelt, MD, Clive Zent, MD, Diane Jelinek, PhD, Renee Tschumper, Nancy Bone, Gordon Dewald, PhD, Thomas Lin, PhD, Nyla Heerema, PhD, Laura Smith, Michael Grever, MD, John Byrd, MD

Blood (2006) 108 (11): 35.

https://doi.org/10.1182/blood.V108.11.35.35

Published: 2006

Journal Articles

Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL).

Daniel L. Van Dyke, PhD, Kimberly Stockero, Stephanie Fink, Stephanie Smoley, Sarah Paternoster, Susan Schwager, Tait Shanafelt, MD, Clive Zent, MD, Timothy Call, MD, Neil Kay, MD, Gordon Dewald, PhD

Blood (2005) 106 (11): 3278.

https://doi.org/10.1182/blood.V106.11.3278.3278

Published: 2005

Journal Articles

Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL).

Gordon W. Dewald, PhD, Stephanie Fink, Stephanie Smoley, Kimberly Stockero, Sarah Paternoster, Schwager Susan, Erik C. Thorland, PhD, Daniel L. Van Dyke, PhD, Tait Shanafelt, MD, Clive Zent, MD, Timothy Call, MD, Neil Kay, MD

Blood (2005) 106 (11): 3255.

https://doi.org/10.1182/blood.V106.11.3255.3255

Published: 2005

Journal Articles

Long Term Follow up of Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL).

Pankaj Malhotra, William J. Hogan, Mark R. Litzow, Michelle A. Elliott, Angela Dispenzieri, Timothy Call, Neil E. Kay, Clive Zent, Dennis A. Gastineau, Steven M. Ansell, Suzanne Hayman, Morie A. Gertz, Martha Q. Lacy, Luis F. Porrata, David J. Inwards, Ayalew Tefferi

Blood (2005) 106 (11): 5420.

https://doi.org/10.1182/blood.V106.11.5420.5420

Published: 2005

NARROW

Chronic myeloid leukemia with p190 BCR-ABL : prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis

Combination Chemoimmunotherapy with Pentostatin, Cyclophosphamide and Rituximab Shows Significant Clinical Activity with Low Accompanying Toxicity in Previously Untreated B-Chronic Lymphocytic Leukemia.

Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL).

Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL).

Long Term Follow up of Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Chronic myeloid leukemia with p190 BCR-ABL : prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis

Combination Chemoimmunotherapy with Pentostatin, Cyclophosphamide and Rituximab Shows Significant Clinical Activity with Low Accompanying Toxicity in Previously Untreated B-Chronic Lymphocytic Leukemia.

Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL).

Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL).

Long Term Follow up of Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only